Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation.

Clinical remission Endoscopic remission Fecal calprotectin Irritable bowel syndrome-like symptoms  Ulcerative colitis

Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2019
Historique:
pubmed: 17 12 2018
medline: 10 4 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

Ulcerative colitis (UC) patients in clinical remission often experience irritable bowel syndrome (IBS)-like symptoms. The prevalence rate of UC patients meeting the definition of IBS, such as shown by the Rome criteria, is significantly higher in those without ongoing clinical activity as compared to healthy controls. Several studies have investigated residual low-grade inflammation found in colonic mucosa of quiescent UC patients and its association with development of IBS-like symptoms. In these patients, residual colonic inflammation was evaluated using endoscopy and histology findings, as well as fecal calprotectin level and shown to not be simply associated with the presence of IBS-like symptoms in UC patients in clinical remission. However, these results are limited by the low number of related investigations conducted. Additional appropriately designed studies are necessary to confirm the relationship of low-grade colonic inflammation with IBS-like symptoms associated with UC.

Identifiants

pubmed: 30554229
pii: 000494412
doi: 10.1159/000494412
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-51

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Shunji Ishihara (S)

Inflammatory Bowel Disease Center, Shimane University Hospital, Izumo, Japan, si360405@med.shimane-u.ac.jp.
Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan, si360405@med.shimane-u.ac.jp.

Kousaku Kawashima (K)

Inflammatory Bowel Disease Center, Shimane University Hospital, Izumo, Japan.
Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Nobuhiko Fukuba (N)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Yasumasa Tada (Y)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Satoshi Kotani (S)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Yoshiyuki Mishima (Y)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Naoki Oshima (N)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Yoshikazu Kinoshita (Y)

Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH